Effects of creatine supplementation on muscle wasting and glucose homeostasis in rats treated with dexamethasone

Amino Acids

Volumn 42, Issue 5, 2012, Pages 1695-1701

  Nicastro, Humberto ^a   Gualano, Bruno ^a   De Moraes, Wilson Max Almeida Monteiro ^a   De Salles Painelli, Vitor ^a   Da Luz, Claudia Ribeiro ^a   Dos Santos Costa, Andre ^a   De Salvi Guimarães, Fabiana ^a   Medeiros, Alessandra ^a,b   Brum, Patricia Chakur ^a   Lancha Jr , Antonio Herbert ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Atrophy; Glucocorticoid; Glucose homeostasis; GLUT 4

Indexed keywords

CREATINE; DEXAMETHASONE; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; PHOSPHOSERINE; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXTENSOR DIGITORUM LONGUS MUSCLE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HYPERGLYCEMIA; INSULIN RESISTANCE; MUSCLE ATROPHY; MUSCLE MASS; NONHUMAN; PLANTARIS MUSCLE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SUPPLEMENTATION;

ANIMALS; BLOOD GLUCOSE; CREATINE; DEXAMETHASONE; DRINKING WATER; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN RESISTANCE; MALE; MUSCLE, SKELETAL; MUSCULAR ATROPHY; PROTO-ONCOGENE PROTEINS C-AKT; RATS;

ANIMALIA; RATTUS;

EID: 84862771900     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-011-0871-9     Document Type: Article

References (24)

1. Adami GF, Cordera R, Andraghetti G, Camerini GB, Marinari GM, Scopinaro N (2004) Changes in serum ghrelin concentration following biliopancreatic diversion for obesity. Obes Res 12:684-687 (Pubitemid 41132512)
2. Bernal-Mizrachi C, Weng S, Feng C, Finck BN, Knutsen RH, Leone TC, Coleman T, Mecham RP, Kelly DP, Semenkovich CF (2003) Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice. Nat Med 9:1069-1075 (Pubitemid 37021788)
3. Campos AR, Serafini LN, Sobreira C, Menezes LG, Martinez JA (2006) Creatine intake attenuates corticosteroid-induced impairment of voluntary running in hamsters. Appl Physiol Nutr Metab 31:490-494
4. Clarke BA, Drujan D, Willis MS, Murphy LO, Corpina RA, Burova E, Rakhilin SV, Stitt TN, Patterson C, Latres E, Glass DJ (2007) The E3 ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab 6:376-385 (Pubitemid 350011998)
5. Gilson H, Schakman O, Combaret L, Lause P, Grobet L, Attaix D, Ketelslegers JM, Thissen JP (2007) Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy. Endocrinology 148:452-460 (Pubitemid 46021477)
6. Giorgino F, Almahfouz A, Goodyear LJ, Smith RJ (1993) Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo. J Clin Invest 91:2020-2030 (Pubitemid 23141474)
7. Gualano B, Novaes RB, Artioli GG, Freire TO, Coelho DF, Scagliusi FB, Rogeri PS, Roschel H, Ugrinowitsch C, Lancha AH Jr (2008) Effects of creatine supplementation on glucose tolerance and insulin sensitivity in sedentary healthy males undergoing aerobic training. Amino Acids 34:245-250 (Pubitemid 351238269)
8. Gualano B, Artioli GG, Poortmans JR, Lancha Junior AH (2010a) Exploring the therapeutic role of creatine supplementation. Amino Acids 38:31-44
9. Gualano B, de Salles Painneli V, Roschel H, Artioli GG, Junior MN, Lucia de Sa Pinto A, Rossi da Silva ME, Cunha MR, Otaduy MC, da Costa Leite C, Ferreira JC, Pereira RM, Brum PC, Bonfa E, Lancha AHJ (2010b) Creatine in type 2 Diabetes: a randomized, double-blind, placebo-controlled trial. Med Sci Sports Exerc (in press)
10. Hasselgren PO (1999) Glucocorticoids and muscle catabolism. Curr Opin Clin Nutr Metab Care 2:201-205
11. Kauvar DS, Baer DG, Walters TJ (2007) Influence of systemic hypotension on skeletal muscle ischemia-reperfusion injury after 4-hour tourniquet application. J Surg Educ 64:273-277 (Pubitemid 350018613)
12. Kley RA, Vorgerd M, Tarnopolsky MA (2007) Creatine for treating muscle disorders. Cochrane Database Syst Rev: CD004760
13. Kley RA, Tarnopolsky MA, Vorgerd M (2008) Creatine treatment in muscle disorders: a meta-analysis of randomised controlled trials. J Neurol Neurosurg Psychiatry 79:366-367 (Pubitemid 351441487)
14. Louis M, Poortmans JR, Francaux M, Berre J, Boisseau N, Brassine E, Cuthbertson DJ, Smith K, Babraj JA, Waddell T, Rennie MJ (2003) No effect of creatine supplementation on human myofibrillar and sarcoplasmic protein synthesis after resistance exercise. Am J Physiol Endocrinol Metab 285:E1089-E1094 (Pubitemid 37296331)
15. Menezes LG, Sobreira C, Neder L, Rodrigues-Junior AL, Martinez JA (2007) Creatine supplementation attenuates corticosteroidinduced muscle wasting and impairment of exercise performance in rats. J Appl Physiol 102:698-703 (Pubitemid 46220901)
16. Op't Eijnde B, Richter EA, Henquin JC, Kiens B, Hespel P (2001a) Effect of creatine supplementation on creatine and glycogen content in rat skeletal muscle. Acta Physiol Scand 171:169-176 (Pubitemid 33757151)
17. Op't Eijnde B, Urso B, Richter EA, Greenhaff PL, Hespel P (2001b) Effect of oral creatine supplementation on human muscle GLUT4 protein content after immobilization. Diabetes 50:18-23 (Pubitemid 32047975)
18. Op't Eijnde B, Jijakli H, Hespel P, Malaisse WJ (2006) Creatine supplementation increases soleus muscle creatine content and lowers the insulinogenic index in an animal model of inherited type 2 diabetes. Int J Mol Med 17:1077-1084
19. Parise G, Mihic S, MacLennan D, Yarasheski KE, Tarnopolsky MA (2001) Effects of acute creatine monohydrate supplementation on leucine kinetics and mixed-muscle protein synthesis. J Appl Physiol 91:1041-1047 (Pubitemid 32803894)
20. Rooney K, Bryson J, Phuyal J, Denyer G, Caterson I, Thompson C (2002) Creatine supplementation alters insulin secretion and glucose homeostasis in vivo. Metabolism 51:518-522 (Pubitemid 34406572)
21. Roy BD, Bourgeois JM, Mahoney DJ, Tarnopolsky MA (2002) Dietary supplementation with creatine monohydrate prevents corticosteroid-induced attenuation of growth in young rats. Can J Physiol Pharmacol 80:1008-1014 (Pubitemid 35408541)
22. Tarnopolsky M, Martin J (1999) Creatine monohydrate increases strength in patients with neuromuscular disease. Neurology 52:854-857 (Pubitemid 29120197)
23. Tarnopolsky MA, Bourgeois JM, Snow R, Keys S, Roy BD, Kwiecien JM, Turnbull J (2003) Histological assessment of intermediateand long-term creatine monohydrate supplementation in mice and rats. Am J Physiol Regul Integr Comp Physiol 285:R762-R769 (Pubitemid 37169138)
24. Waddell DS, Baehr LM, van den Brandt J, Johnsen SA, Reichardt HM, Furlow JD, Bodine SC (2008) The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophyassociated MuRF1 gene. Am J Physiol Endocrinol Metab 295:E785-E797